Conference / Tradeshow

Advanced Therapies Week

Date

Tuesday, January 25, 2022 - Friday, January 28, 2022

Location

Miami, FL
Attendee at Advanced Therapies Week

Event Overview

Join us at Advanced Therapies Week (fka Phacillitate) for the largest expo on cell and gene therapy of the year. Features of the expo include a Match Zone for networking, five learning tracks with presentations from subject matter experts, and interactive demos.

Charles River scientists will be providing three presentations during the expo and will be leading a 90-minute panel.

Presentations
Thursday, January 27 | 9:30 – 10:30 AM EST
Plenary Track, Roundtable Discussions Session
Digitalization; Implementing a Unified Platform to Enable Transformative Progress for Cell and Gene Therapy Timelines
Matthew Hewitt, PhD, Director of Scientific Services Cell and Gene Therapy 
Join this collaborative session with Matthew Hewitt, B.A., Ph.D., Executive Director, Scientific Services Cell and Gene Therapy, Charles River & Trent Carrier, Ph.D., MBA, Chief Operating Officer, L7 Informatics for a dynamic discussion offering multiple perspectives and strategies in approaching today's CGT challenges. Topics covered include:
  • Data challenges with CG&T manufacturing (small batch, multi-product, multi-vendor equipment)
  • Integrating end-to-end visibility for the patient journey with manufacturing and analytical testing
  • Strategy for transitioning from traditional data systems to next-generation data systems for scaling
  • Digitalization approaches to balance the need for flexibility and change control in GMP environment
Thursday, January 27 | 11:00 – 12:30 PM EST
From Collection to Delivery
Arriving at Your Cell & Gene Therapy Destination: Navigating the Many Journeys Within the Journey
Matthew Hewitt, PhD, Director of Scientific Services Cell and Gene Therapy 
Attendees will learn from industry experts about:
  • Current & future state of the cell and gene therapy development and manufacturing
  • Comprehensive thinking and approaches central to success
  • Potential bottlenecks and pre-emptive solutions
  • Critical considerations in facility design
  • Evolving regulatory landscape and the dynamics specific to cell and gene therapies
Thursday, January 27 | 11:00 – 12:30 PM EST
Pipeline Updates and Therapeutic Area Advancement
Clinical Pipelines: Allogeneic Cell Therapies - Effective Donor Sourcing Strategies to Enhance Downstream Efficiency and Scalability of Allogeneic Cell Therapies
Kimberly Negrin, PhD, Associate Sales Director, Cell Therapy
Attendees will learn from industry experts about:
  • Examining the impact of inter-donor variability of cellular source material
  • How streamlined donor management can improve outcomes utilizing inherently variable starting material for manufacture of off-the-shelf therapies
  • Benchmarking how raw material supply partners can help mitigate risk and provide sustainable growth strategies to overcome supply chain hurdles – a case study
Thursday, January 27 | 1:30 – 3:00 PM EST
Pipeline Updates and Therapeutic Area Advancement
Development in Future Therapies for Non-Oncology Indications
Matthew Hewitt, PhD, Director of Scientific Services Cell and Gene Therapy
Friday, January 28 | 9:00 AM – 10:30 PM EST
Pipeline Updates and Therapeutic Area Advancement
Clinical Pipelines: Rare and Difficult Indications - a. Presentation title: Integrated and Aligned End-to-End Vector and Cell Production: Charles River C&GT 360° Portfolio
Daniel Smith, PhD, FRSB, Executive Director, Global Cell and Gene Therapy Portfolio
Attendees will learn from industry experts about:
  • Charles River is building a comprehensive portfolio of integrated services from early discovery to clinical and commercial C&GT manufacturing.
  • We will present on our integrated and aligned C&GT development and manufacturing services, profiling key strategic partnerships that augment the service offering.